Owens & Minor names Mark Zacur as chief procurement officer
Mark Zacur
Owens & Minor Inc (Richmond, VA) announced the hiring of Mark Zacur as SVP, chief procurement officer. Zacur has over 20 years of experience in supplier management, including various leadership roles in healthcare distribution and manufacturing. He has also served as a Board Member of The Health Industry Distributors Association (HIDA) since 2012 as well as HIDA’s Board Chairman in 2015. Mark also serves as a Board Member at St. Clair Hospital, a non-profit and independent acute care medical center (a Watson Health Top 100 Hospital and member of the Mayo Clinic Care Network) located in southwestern Pennsylvania.
“Mark brings extensive professional experiences from his prior executive leadership roles,” said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor. “We recognize that Mark’s expertise and successful track record will be instrumental to growing our business.”
He succeeds Charlie Colpo, SVP, strategic supplier management, who will retire in August.
Cardinal Health names Stephen Mason as leader of Medical segment
Cardinal Health (Dublin, OH) announced that Stephen Mason, president of the Cardinal Health at-Home Solutions business, was promoted to CEO of Cardinal Health’s Medical segment. Mason will succeed Jon Giacomin, who will be departing the company in mid-August to assume a CEO position at a privately-held company. Since 2016, Mason has overseen Cardinal Health at-Home Solutions, a component of the Medical segment that has delivered strong and consistent growth. Prior to that, he led Cardinal Health’s Kinray pharmaceutical distribution business. Mason also has deep experience leading sales, sales operations, and sourcing teams within the company’s Pharmaceutical Distribution business, including the Consumer Health, Sales Administration, Retail Independent Sales, and Retail National Accounts teams.
Mike Kaufmann, CEO of Cardinal Health, commented, “We are pleased to name Steve Mason as the new CEO of our Medical segment. He is a proven leader who has consistently generated positive results in every business he has led within the company. With Steve at the helm, we look forward to building on the steady progress underway in the Medical segment as we continue to execute on our strategy to generate improved performance and long-term growth.
Sekisui Diagnostics announces relocation of global headquarters
Sekisui Diagnostics (Burlington, MA) announced that, as of June 26, 2019, its global headquarters has relocated to One Wall Street, Burlington, Massachusetts. A main driver for the move was to break away from the one room, open office structure and unused lab area, to create a modern, inviting space that supports effective collaboration but also appreciates the need for individual work, the company said.
Henry Schein Medical announces availability of Medpod MobileDoc 2, driven by Uber Health
Henry Schein Medical, the U.S. medical business of Henry Schein Inc (Melville, NY) and the exclusive distributor of Medpod Inc, announced the availability of Medpod MobileDoc 2, integrated with Uber Health. The medical microcart, which is packed into a portable, carry-on sized case, will enable healthcare practitioners to conduct remote telediagnostic examinations for patients in non-traditional care settings, such as homes, offices, schools, ambulances, and senior care facilities.
“Henry Schein Medical is eager to bring this expanded Medpod offering to our customers in multiple market segments, helping transform their practices and improve relationships with patients looking for convenient access to health care,” said Brad Connett, President, U.S. Medical Group, Henry Schein. “Together with Medpod and Uber Health, we look forward to expanding off-site point-of-care options our customers can rely on to meet their patients’ portable needs.”
Medpod and Uber Health have entered into an agreement, with Uber Health providing Medpod access to Uber Health’s browser-based online dashboard, allowing for the integration of the Uber Health service directly into Medpod’s end-to-end telediagnostics platform. As a result, practitioners with a MobileDoc or MobileDoc 2 can dispatch an Uber driver partner to a patient’s location, or arrange for a patient to be driven by Uber Health to a clinical care setting.
“Our new partnership with Uber Health, and launch of Medpod MobileDoc 2, will help break down barriers that had previously required diagnostic exams to take place in traditional care settings,” said Jack Tawil, Chairman and Chief Executive Officer, Medpod Inc. “With the MobileDoc 2’s ability to take the physician office environment into patients’ homes and other non-traditional settings, we can create new convenient care delivery options and access points for patients.”
Roche expands the Global Access Program to include tests for TB, Hepatitis, HPV
Roche (Switzerland) announced the Global Access Program is expanding beyond HIV to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle income country programs where the disease burden is the highest. In total, the Global Access Program now includes molecular diagnostics for HIV-1 viral load, HIV-1 and HIV-2 early infant diagnosis, the cobas Plasma Separation Card – an innovative plasma collection device, MTB and MTB – RIF/INH, Hepatitis B and C, and Human Papillomavirus. All these assays run on the cobas 4800/6800/8800 platforms for various testing volume needs enabled by the cobas Plasma Separation Card that transports samples from remote areas/sites to the central lab for further processing.
CVS to move into kidney dialysis market
CVS Health will start clinical trials of a home kidney dialysis device this week. CVS will test HemoCare, a dialysis device created by Dakea Research and Development. The clinical trial will enroll about 70 patients and will work to compare the results for the at-home test to when dialysis is performed by a nurse. The trial is expected to be completed at the end of 2020. If successful, the device would hit the market in late 2021. CVS doesn’t expect to perform dialysis at its own facilities or stores. The move would set up CVS as a competitor for two of the largest operators of U.S. dialysis centers, Fresenius Medical Care and DaVita.
Intermountain launches new IT startup aimed at value-based care
Intermountain Healthcare (Salt Lake City, Utah) launched Castell, a new company aimed at boosting value-based care capabilities among providers and payers. Rajesh Shrestha was named president and CEO of the company, in addition to his role as Intermountain VP and COO of Community Based Care. Castell is a health IT platform that “will enable the health system as well as other organizations to accelerate their transition from a volume to value,” Intermountain said. Castell will offer a comprehensive platform of tools and services to support transformation and improvement, including: A proven value-based clinical care model called “Reimagined Primary Care”; a technology and analytics platform to guide care; streamlined affiliated network management; digital tools to address virtual care, patient experience, and social determinants of health; access to cutting-edge initiatives and innovation coming out of Intermountain Healthcare; and the opportunity to utilize care pathways and clinical best practices developed by Intermountain Healthcare.